{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/larazotide.json","peptide":{"slug":"larazotide","name":"Larazotide","url":"https://peptidescanner.com/peptides/larazotide/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":13,"entries":[{"objectId":"story:clinicaltrials-gov-nct00362856-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00362856","domain":"Clinical trials","dateInSource":"2017-09-12","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00362856-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00362856-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#clinicaltrials-gov-nct00362856-larazotide-v1","contentSha256":"29aaef4a4f5950051ba815a5598490e89d9202590fe6dea3f34c66803157e826"},{"objectId":"story:clinicaltrials-gov-nct00386165-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00386165","domain":"Clinical trials","dateInSource":"2017-09-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00386165-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00386165-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#clinicaltrials-gov-nct00386165-larazotide-v1","contentSha256":"ba3846e013b3bbb7312a40eceaf9daef3139455181a6afcdebf93c5626e88b79"},{"objectId":"story:clinicaltrials-gov-nct00386490-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00386490","domain":"Clinical trials","dateInSource":"2017-09-12","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00386490-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00386490-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#clinicaltrials-gov-nct00386490-larazotide-v1","contentSha256":"8e2461069125725ea28ed43c5fa50378bc505f956a543f7a679491d82aba0fee"},{"objectId":"story:clinicaltrials-gov-nct00492960-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00492960","domain":"Clinical trials","dateInSource":"2017-09-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00492960-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00492960-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#clinicaltrials-gov-nct00492960-larazotide-v1","contentSha256":"20fb1e4fc5ce9c8574a2ac661faceb323725541786a2a8fac1d6d8400554e50a"},{"objectId":"story:clinicaltrials-gov-nct00620451-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00620451","domain":"Clinical trials","dateInSource":"2017-09-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00620451-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00620451-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#clinicaltrials-gov-nct00620451-larazotide-v1","contentSha256":"fdab1772868811e9d0010fc5594b4350097731cf354935db2a22c68b5766bd1f"},{"objectId":"story:clinicaltrials-gov-nct00889473-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00889473","domain":"Clinical trials","dateInSource":"2017-09-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00889473-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct00889473-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#clinicaltrials-gov-nct00889473-larazotide-v1","contentSha256":"6097f59d372502b0586e3cd4b3fb066297f3216901134ef52e02a234856639f2"},{"objectId":"story:clinicaltrials-gov-nct01396213-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01396213","domain":"Clinical trials","dateInSource":"2017-09-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01396213-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct01396213-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#clinicaltrials-gov-nct01396213-larazotide-v1","contentSha256":"30da5251474f764276d4052bfcd755ecab7312671aac8836c23acf887818c802"},{"objectId":"story:clinicaltrials-gov-nct05747534-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT05747534","domain":"Clinical trials","dateInSource":"2026-08-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05747534-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#clinicaltrials-gov-nct05747534-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#clinicaltrials-gov-nct05747534-larazotide-v1","contentSha256":"587f9cf0f950bac72e1cf531227c541865463c166cac3585afc864d51253ee54"},{"objectId":"story:pubmed-pmid-23336683-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Commentary: larazotide acetate - an exciting new development for coeliac patients?","domain":"Literature metadata","dateInSource":"2018-12-02","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23336683-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-23336683-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#pubmed-pmid-23336683-larazotide-v1","contentSha256":"cf07ff0916a1cd9f244ec738ca20b7647a1ea16d9dfebf2db7eafa3fa30c54cb"},{"objectId":"story:pubmed-pmid-23336684-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors' reply.","domain":"Literature metadata","dateInSource":"2018-12-02","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23336684-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-23336684-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#pubmed-pmid-23336684-larazotide-v1","contentSha256":"3652bad4b6cee104c53b898200c55bf3c970bfac7be5f1def688b72d56cdb330"},{"objectId":"story:pubmed-pmid-26983338-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"[Larazotide as an option in case of failure of a gluten-free diet].","domain":"Literature metadata","dateInSource":"2021-08-27","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26983338-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-26983338-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#pubmed-pmid-26983338-larazotide-v1","contentSha256":"cc0cd5ca6733e659aceb7d86076658a32224a6b9915dc6455cbcbb20fe22017a"},{"objectId":"story:pubmed-pmid-35211683-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series.","domain":"Literature metadata","dateInSource":"2022-03-17","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35211683-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-35211683-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#pubmed-pmid-35211683-larazotide-v1","contentSha256":"cb28c8f66fefb83e4a44fe32fb4d88c4dcb4b7f8368e7b9ec1a279f01e7731dc"},{"objectId":"story:pubmed-pmid-40737433-larazotide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide.","domain":"Literature metadata","dateInSource":"2026-08-12","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40737433-larazotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.json#pubmed-pmid-40737433-larazotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/larazotide.md#pubmed-pmid-40737433-larazotide-v1","contentSha256":"2580a8aee1c2c359f7232d54ea09f26c79c7d9cfe6bdca9f28b5d87941e939c4"}]}
